Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland.
Methods Mol Biol. 2021;2283:123-130. doi: 10.1007/978-1-0716-1302-3_13.
Outer membrane vesicles (OMV) shed by pathogenic bacteria have multifunctional roles in disease initiation and progression. Further, their efficacy as novel vaccines has underscored their importance as potential therapeutics. Consequently, to advance allied research related to their immunogenicity and pathogenicity it is important to separate these vesicular structures from parental cells and demonstrate them to be free from cellular debris and other non-vesicle-related constituents such as protein aggregates. To do so represents a key step in initiating OMV-related studies and the techniques and strategies adopted by the H. pylori community to achieve this will be the focus of this chapter.The key methods used typically to obtain a heterogeneous mixture of OMV (size range: ~20-300 nm in diameter) include growth of bacteria in broth culture followed by differential centrifugation, filtration, and concentration to separate OMV from the intact organisms. Additional measures may be adopted to further size-fractionate the population of OMV including gel filtration or density gradient ultra-centrifugation in order to facilitate differentiation between the activities of small versus large OMV, as recent studies have demonstrated differential modes of entry into host cells as well as size-dependent differences in the OMV proteome (Turner et al., Front Immunol 9:1466, 2018). The OMV from H. pylori harbor many of the virulence factors associated with gastric disease including the CagA oncoprotein, the cytotoxin VacA, and the HtrA protease (Olofsson et al., mBio 5:e00979-14, 2014; Mullaney et al., Proteomics Clin Appl 3:785-96, 2009) and their close association with areas of cell-cell contact and efficient endocytosis supports a role for these complexes in gastric disease (Turkina et al., FEMS Microbiol Lett 362:fnv076, 2015).
外膜囊泡(OMV)由致病性细菌脱落,在疾病的起始和进展中具有多功能作用。此外,它们作为新型疫苗的功效突显了它们作为潜在治疗剂的重要性。因此,为了推进与它们的免疫原性和致病性相关的联合研究,将这些囊泡结构与亲本细胞分离并证明它们不含细胞碎片和其他非囊泡相关成分(如蛋白聚集体)是很重要的。做到这一点是启动 OMV 相关研究的关键步骤,幽门螺杆菌研究界采用的技术和策略将是本章的重点。
通常用于获得 OMV 异质混合物(大小范围:~20-300nm 直径)的关键方法包括在肉汤培养物中生长细菌,然后进行差速离心、过滤和浓缩,以将 OMV 与完整的生物体分离。可能会采取其他措施进一步对 OMV 群体进行大小分级分离,包括凝胶过滤或密度梯度超速离心,以便区分小 OMV 和大 OMV 的活性,因为最近的研究表明进入宿主细胞的模式不同,以及 OMV 蛋白质组中存在大小依赖性差异(Turner 等人,Front Immunol 9:1466,2018)。幽门螺杆菌的 OMV 携带许多与胃病相关的毒力因子,包括 CagA 癌蛋白、细胞毒素 VacA 和 HtrA 蛋白酶(Olofsson 等人,mBio 5:e00979-14,2014 年;Mullaney 等人,Proteomics Clin Appl 3:785-96,2009 年),它们与细胞-细胞接触区的密切关联和有效的内吞作用支持这些复合物在胃病中的作用(Turkina 等人,FEMS Microbiol Lett 362:fnv076,2015 年)。